EUVIMEDEUVIMED entdecken
Open Access

Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [ 18 F]PSMA-1007 PET/CT

Matteo Bauckneht, Francesca D'Amico, Domenico Albano, Michele Balma, Camilla Cabrini, Francesco Dondi, Tania Di Raimondo, Virginia Liberini, Luca Sofia, Simona Peano, Mattia Riondato, Giuseppe Fornarini und 16 weitere

Journal of Nuclear Medicine · 2024

DOI: 10.2967/jnumed.124.267751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Nuclear Medicine, 2024. Verfasst von Matteo Bauckneht und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Genova, Genova, Italy; matteo.bauckneht@unige.it. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Bone Neoplasms, Oligopeptides. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Unspecific bone uptake (UBU) related to [18F]PSMA-1007 PET/CT imaging represents a clinical challenge. We aimed to assess whether a combination of clinical, biochemical, and imaging parameters could predict skeletal metastases in patients with [18F]PSMA-1007 bone focal uptake, aiding in result interpretation.

Methods

We retrospectively analyzed [18F]PSMA-1007 PET/CT performed in hormone-sensitive prostate cancer (PCa) patients at 3 tertiary-level cancer centers. A fourth center was involved in performing an external validation. For each, a volume of interest was drawn using a threshold method to extract SUVmax, SUVmean, PSMA tumor volume, and total lesion PSMA. The same volume of interest was applied to CT images to calculate the mean Hounsfield units (HUmean) and maximum Hounsfield units. Clinical and laboratory data were collected from electronic medical records. A composite reference standard, including follow-up histopathology, biochemistry, and imaging data, was used to distinguish between PCa bone metastases and UBU. PET readers with less (n = 2) or more (n = 2) experience, masked to the reference standard, were asked to visually rate a subset of focal bone uptake (n = 178) as PCa metastases or not.

Results

In total, 448 bone [18F]PSMA-1007 focal uptake specimens were identified in 267 PCa patients. Of the 448 uptake samples, 188 (41.9%) corresponded to PCa metastases. Ongoing androgen deprivation therapy at PET/CT (P < 0.001) with determination of SUVmax (P < 0.001) and HUmean (P < 0.001) independently predicted bone metastases. A composite prediction score, the bone uptake metastatic probability (BUMP) score, achieving an area under the receiver-operating-characteristic curve (AUC) of 0.87, was validated through a 10-fold internal and external validation (n = 89 bone uptake, 51% metastatic; AUC, 0.92). The BUMP score's AUC was significantly higher than that of HUmean (AUC, 0.62) and remained high among lesions with HUmean in the first tertile (AUC, 0.80). A decision-curve analysis showed a higher net benefit with the score. Compared with the visual assessment, the BUMP score provided added value in terms of specificity in less-experienced PET readers (88% vs. 54%, P < 0.001).

Conclusion

The BUMP score accurately distinguished UBU from bone metastases in PCa patients with [18F]PSMA-1007 focal bone uptake at PET imaging, offering additional value compared with the simple assessment of the osteoblastic CT correlate. Its use could help clinicians interpret imaging results, particularly those with less experience, potentially reducing the risk of patient overstaging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPositron Emission Tomography Computed TomographyBone NeoplasmsOligopeptidesHumansMaleAgedRetrospective StudiesMiddle AgedNiacinamideFluorine RadioisotopesBiological TransportBone and BonesAged, 80 and over

Stichwörter der Autor:innen

PETpredictionprostate cancerprostate-specific membrane antigenunspecific bone uptake

Substanzen

PSMA-1007OligopeptidesNiacinamideFluorine RadioisotopesFluorine-18

Autor:innen und Institutionen

  • Department of Health Sciences, University of Genova, Genova, Italy; matteo.bauckneht@unige.it.
  • Nuclear Medicine, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
  • Nuclear Medicine, ASST Spedali Civili di Brescia, Brescia, Italy.
  • University of Brescia, Brescia, Italy.
  • Nuclear Medicine, S. Croce e Carle Hospital, Cuneo, Italy.
  • Department of Health Sciences, University of Genova, Genova, Italy.

Zitieren

APA

Bauckneht, M., D'Amico, F., Albano, D., Balma, M., Cabrini, C., Dondi, F., Di Raimondo, T., Liberini, V., Sofia, L., Peano, S., Riondato, M., Fornarini, G., Laudicella, R., Carmisciano, L., Lopci, E., Zanca, R., Rodari, M., Raffa, S., Donegani, M. I., …, & Signori, A. (2024). Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [ 18 F]PSMA-1007 PET/CT. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.124.267751

Vancouver

Bauckneht M, D'Amico F, Albano D, Balma M, Cabrini C, Dondi F, et al. Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [ 18 F]PSMA-1007 PET/CT. Journal of Nuclear Medicine. 2024. doi:10.2967/jnumed.124.267751

BibTeX
@article{Bauckneht2024,
  author = {Bauckneht, Matteo and D'Amico, Francesca and Albano, Domenico and Balma, Michele and Cabrini, Camilla and Dondi, Francesco and Di Raimondo, Tania and Liberini, Virginia and Sofia, Luca and Peano, Simona and Riondato, Mattia and Fornarini, Giuseppe and Laudicella, Riccardo and Carmisciano, Luca and Lopci, Egesta and Zanca, Roberta and Rodari, Marcello and Raffa, Stefano and Donegani, Maria Isabella and Dubois, Daniela and Peñuela, Leonardo and Marini, Cecilia and Bertagna, Francesco and Papaleo, Alberto and Morbelli, Silvia and Sambuceti, Gianmario and Ponzano, Marta and Signori, Alessio},
  title = {Composite Prediction Score to Interpret Bone Focal Uptake in Hormone-Sensitive Prostate Cancer Patients Imaged with [ 18 F]PSMA-1007 PET/CT},
  journal = {Journal of Nuclear Medicine},
  year = {2024},
  doi = {10.2967/jnumed.124.267751}
}
Kostenlos starten →